ACTRN12612000025831尚未招募未知
For patients with liver disease, is HepaFat Scan as accurate (ie has equal or better sensitivity and specificity) as liver biopsy for measuring liver fat?’
Resonance Health Analysis Services Limited0 个研究点目标入组 90 人开始时间: 2012年1月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Age 18-65 years
- •Confirmed diagnosis of liver disease
- •Liver biopsy within 12 months prior to entry into the study
- •Alcohol consumption <20 grams/day for men and <10 grams/day for women.
排除标准
- •Inability to provide informed consent
- •Contraindications for MRI
- •Ischemic heart disease as determined by history or abnormal ECG.
- •Pregnancy or lactation.
- •Malignancy (excluding basal cell or squamous cell skin cancers)
研究者
相似试验
尚未招募
不适用
on-alcoholic Fatty Liver Disease Dietary TrialACTRN12612000841875Catherine Properzi66
尚未招募
不适用
on alcoloholic liver disease in people living with HIVCTRI/2020/01/022630Maulana Azad Medical College
招募中
不适用
ear infrared laser confocal endomicroscopy of the human liver.ACTRN12608000152325Optiscan Pty Ltd20
已完成
不适用
Non-invasive Liver Screening for Risk Assessment for Coronary Heart DiseaseCoronary DiseaseNon-alcoholic Fatty Liver DiseaseElasticity Imaging TechniquesNCT02779946University of Leipzig216
Unknown
不适用
Non-invasive Evaluation of Hepatic Fibrosis in Patients With the Metabolic SyndromeMetabolic SyndromeNCT00399932Cliniques universitaires Saint-Luc- Université Catholique de Louvain75